NDC product
Proctozone-G
NDC 57237-338 · Rising Pharma Holdings, Inc.
Key facts
| Product NDC | 57237-338 |
|---|---|
| Proprietary name | Proctozone-G |
| Nonproprietary name | Glycerin |
| Substances | GLYCERIN |
| Dosage form | SUPPOSITORY |
| Route | RECTAL |
| Labeler | Rising Pharma Holdings, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M007.54 |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC] |
| Marketing start | Jul 31, 2025 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: